Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Intellipharmaceutics International Inc.

NASDAQ: IPCIHealthcare / Drug Delivery / Canada
0.380000.00Vol 2 865 0501Y Perf -94.71%
Feb 21st, 2019 15:59
BID0.3600 ASK0.3900
Open0.3800 Previous Close0.3800
Pre-Market0.36 After-Trading-
 -0.02 -5.26%  - -%
Target Price
27.50 
Analyst Rating
Hold 3.00
Potencial %
7 136.84 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)7 
Earnings Rating
Neutral
Price Range Ratio 52wk %
2.61 
Earnings Date
22nd Feb 2019

Today's Price Range

0.34000.4000

 

52wk Range

0.20007.10

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
31.03%
3 Months
-26.21%
6 Months
-85.10%
1 Year
-94.71%
3 Years
-98.42%
5 Years
-98.97%

Quotes

Name / TickerPriceChg.Chg.%
IPCI0.38000.00000.00
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.10
Current Ratio
0.20
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-31.30
Leverage Ratio -2.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
90.50
EBIT Margin
-503.10
EBITDA Margin
-476.60
Pre-tax Profit Margin
-199.80
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
62.79
PS Ratios
3.69
Price to Cash Flow
-
Price to Free Cash Flow
-0.40
Cash Flow Per Share
-2.95
Price to Tangible Book
-0.52
Book Value per Share
-
Enterprise Value (in ths.)
3 393
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
123 469.00
ROE last 12 Months
435.21
Return on Assets (5Y Avg)
-136.51
ROA last 12 Months
-205.68
Return on Capital (5Y Avg)
-293.63
ROC last 12 Months
-
Return on invested Capital Q
-
Return on invested Capital Y
-387.94
Assets Turnover
0.20
Receivables Turnover
1.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
-
Revenue per Share
0.09
Revenue Growth 3 Years
-18.14
Revenue Growth 5 Years
3.26
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.91-
Q02 2018-0.70-0.700.00
Q01 2018-0.50-0.90-80.00
Q04 2017-0.70-0.80-14.29
Q03 2017-0.40-0.80-100.00
Q02 2017-0.50-0.60-20.00
Q01 2017-0.08-0.0712.50
Q04 2016-0.06-0.14-133.33
Earnings Per EndEstimateRevision %Trend
8/2018 QR-0.400.00-
11/2018 QR0.00--
11/2018 FY-1.950.00-
11/2019 FY-1.000.00-
Next Report Date22nd Feb 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2 865 050
Shares Outstanding (in ths.)19 525
Trades Count2 098
Dollar Volume1 009 538
Avg. Volume1 292 463
Avg. Weekly Volume3 018 222
Avg. Monthly Volume1 772 045
Avg. Quarterly Volume1 697 943

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

39%61%

Bearish Bullish

70%30%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
1 (33.33 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (100.00 %)
2 (66.67 %)
2 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Moderate Buy
2.33
Moderate Buy
2.33

There are no comments yet.

News